Abstract

When bacterial pericarditis is suspected, urgent pericardial drainage combined with intravenous antibacterial therapy is mandatory to avert devastating, life-threatening complications. There have been scanty results on antimicrobial susceptibility of common causative microorganisms of bacterial pericarditis; most studies had small sample sizes and were performed decades ago. This prospective study surveyed the causative bacteria in infectious pericardial effusions and their antimicrobial susceptibility among 320 consecutive cardiac patients who underwent pericardiocentesis at Tehran Heart Center between 2007 and 2012, using the European Society of Cardiology (ESC)'s criteria. Staphylococcus spp. (S. epidermidis, S. aureus, S. haemolyticus) were the main causative organisms isolated from cultures of pericardial effusion samples. Other causative organisms were Streptococcus spp., Enterococcus faecium, Pseudomonas aeruginosa, and Acinetobacter baumannii. In the cultures studied, 35% methicillin-resistant Staphylococcus epidermidis (MRSE) and 42.9% methicillin-resistant Staphylococcus aureus (MRSA) were detected. The most effective antimicrobial agents in S. epidermidis were gentamicin, ciprofloxacin, and cefoxitin. Clindamycin was relatively effective. S. aureus was highly susceptible to clindamycin and erythromycin. In cases of S. haemolyticus infection, clindamycin, erythromycin, cefoxitin, and ciprofloxacin were effective antibiotics. In order to diminish the nascence and extension of antimicrobial-resistant pathogens, logical and optimized antimicrobial usage and monitoring in hospitals are highly recommended. It is incumbent on healthcare systems to determine current local resistance patterns by which to guide empiric antimicrobial therapy for specific infections and microorganism types.

Highlights

  • When bacterial pericarditis is suspected, urgent pericardial drainage combined with intravenous antibacterial therapy is mandatory to avert devastating, life-threatening complications

  • A number of factors contribute to this, including the severity of patient illness, predisposition to nosocomial infections, cross-transmission of pathogens characteristic of ward areas within the hospital, and the widespread use of prophylactic and therapeutic anti-infective agents. Appropriate therapy of these infections directed by local resistance data can have significant consequences for both patients and the healthcare system [14,15,16]

  • Pneumococcus is more commonly associated with contiguous spread from an intrathoracic site, while S. aureus is more often involved in hematogenous spread [7]

Read more

Summary

Introduction

When bacterial pericarditis is suspected, urgent pericardial drainage combined with intravenous antibacterial therapy is mandatory to avert devastating, life-threatening complications. To the best of our knowledge, there have been scanty reports about antimicrobial susceptibility of common causative microorganisms of bacterial pericardial effusions, and most studies had small sample sizes and were performed decades ago, while other reports did not specify the exact type of microorganisms and type of antibiotic susceptibility and resistance. Many of these studies have been conducted in developed countries, and epidemiologic aspects of them are not well known in developing countries

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call